Published in Hematology Week, May 3rd, 2010
"We also studied various metabolic parameters. In this 12-week, double-blind, parallel group study, seventy-two drug-naive, first-episode schizophrenia patients were randomized to receive olanzapine+placebo (olanzapine group) or...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.